Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5626
BARK
BARK
$91.7M
| $1.82M | ﹤0.01% |
71,236
+30,861
| +76% | +$1.56M |
|
5627
Kohl's
KSS
$2.16B
| $1.82M | ﹤0.01% |
+51,049
| New | +$2.5M |
|
5628
CALL
Portland General Electric
POR
$5.95B
| $1.82M | ﹤0.01% |
37,700
+23,500
| +165% | +$1.17M |
|
5629
PUT
Global X S&P 500 Covered Call ETF
XYLD
$3.29B
| $1.82M | ﹤0.01% |
42,700
+18,400
| +76% | +$842K |
|
5630
CALL
Kratos Defense & Security Solutions
KTOS
$11.8B
| $1.82M | ﹤0.01% |
131,100
-87,900
| -40% | -$1.37M |
|
5631
Capital Group International Focus Equity ETF
CGXU
$6.68B
| $1.82M | ﹤0.01% |
88,049
+54,947
| +166% | +$1.23M |
|
5632
Nektar Therapeutics
NKTR
$2.52B
| $1.82M | ﹤0.01% |
31,890
-35,416
| -53% | -$2.23M |
|
5633
AptarGroup
ATR
$8.4B
| $1.82M | ﹤0.01% |
17,608
-93,736
| -84% | -$10.2M |
|
5634
PUT
Q2 Holdings
QTWO
$4.05B
| $1.82M | ﹤0.01% |
47,100
-3,500
| -7% | -$170K |
|
5635
CALL
Treace Medical Concepts
TMCI
$293M
| $1.82M | ﹤0.01% |
126,700
-38,700
| -23% | -$652K |
|
5636
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.4B
| $1.82M | ﹤0.01% |
35,644
-181,564
| -84% | -$9.46M |
|
|
NEUE
5637
DELISTED
NeueHealth
NEUE
| $1.82M | ﹤0.01% |
12,476
-7,299
| -37% | -$1.06M |
|
|
IBDQ
5638
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| $1.81M | ﹤0.01% |
73,440
+38,607
| +111% | +$961K |
|
5639
CALL
Lazard
LAZ
$4.28B
| $1.81M | ﹤0.01% |
55,900
-6,700
| -11% | -$226K |
|
5640
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.8B
| $1.81M | ﹤0.01% |
28,058
+25,345
| +934% | +$1.76M |
|
5641
CALL
PubMatic
PUBM
$779M
| $1.81M | ﹤0.01% |
113,900
-45,800
| -29% | -$981K |
|
5642
CALL
Direxion Daily Gold Miners Index Bear 2X ETF
DUST
$74.4M
| $1.81M | ﹤0.01% |
863
+15
| +2% | +$22.6K |
|
|
LIAN
5643
DELISTED
LianBio American Depositary Shares
LIAN
| $1.81M | ﹤0.01% |
837,173
+128,867
| +18% | +$438K |
|
5644
Pacer Developed Markets International Cash Cows 100 ETF
ICOW
$1.85B
| $1.81M | ﹤0.01% |
+67,167
| New | +$2M |
|
|
PR
5645
PUT
Permian Resources
PR
$18.5B
| $1.81M | ﹤0.01% |
302,300
+21,700
| +8% | +$173K |
|
5646
PUT
TransUnion
TRU
$15.1B
| $1.81M | ﹤0.01% |
22,600
-7,400
| -25% | -$637K |
|
5647
Towne Bank
TOWN
$3.47B
| $1.81M | ﹤0.01% |
66,543
-19,788
| -23% | -$565K |
|
5648
Kodak
KODK
$968M
| $1.81M | ﹤0.01% |
389,048
+53,192
| +16% | +$277K |
|
|
TRST
5649
Trustco Bank Corp NY
TRST
$972M
| $1.8M | ﹤0.01% |
58,547
+12,089
| +26% | +$377K |
|
5650
Invesco DB US Dollar Index Bullish Fund
UUP
$353M
| $1.8M | ﹤0.01% |
64,559
-53,002
| -45% | -$1.45M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.